Literature DB >> 16508085

Crystallization of the glycogen-binding domain of the AMP-activated protein kinase beta subunit and preliminary X-ray analysis.

Galina Polekhina1, Susanne C Feil, Abhilasha Gupta, Paul O'Donnell, David Stapleton, Michael W Parker.   

Abstract

AMP-activated protein kinase (AMPK) is an intracellular energy sensor that regulates metabolism in response to energy demand and supply by adjusting the ATP-generating and ATP-consuming pathways. AMPK potentially plays a critical role in diabetes and obesity as it is known to be activated by metforin and rosiglitazone, drugs used for the treatment of type II diabetes. AMPK is a heterotrimer composed of a catalytic alpha subunit and two regulatory subunits, beta and gamma. Mutations in the gamma subunit are known to cause glycogen accumulation, leading to cardiac arrhythmias. Recently, a functional glycogen-binding domain (GBD) has been identified in the beta subunit. Here, the crystallization of GBD in the presence of beta-cyclodextrin is reported together with preliminary X-ray data analysis allowing the determination of the structure by single isomorphous replacement and threefold averaging using in-house X-ray data collected from a selenomethionine-substituted protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16508085      PMCID: PMC1952378          DOI: 10.1107/S1744309104025059

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  16 in total

1.  Expression of the AMP-activated protein kinase beta1 and beta2 subunits in skeletal muscle.

Authors:  Z Chen; J Heierhorst; R J Mann; K I Mitchelhill; B J Michell; L A Witters; G S Lynch; B E Kemp; D Stapleton
Journal:  FEBS Lett       Date:  1999-10-29       Impact factor: 4.124

Review 2.  Management of cellular energy by the AMP-activated protein kinase system.

Authors:  D Grahame Hardie; John W Scott; David A Pan; Emma R Hudson
Journal:  FEBS Lett       Date:  2003-07-03       Impact factor: 4.124

Review 3.  Dealing with energy demand: the AMP-activated protein kinase.

Authors:  B E Kemp; K I Mitchelhill; D Stapleton; B J Michell; Z P Chen; L A Witters
Journal:  Trends Biochem Sci       Date:  1999-01       Impact factor: 13.807

4.  The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

Authors:  Lee G D Fryer; Asha Parbu-Patel; David Carling
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

5.  A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle.

Authors:  D Milan; J T Jeon; C Looft; V Amarger; A Robic; M Thelander; C Rogel-Gaillard; S Paul; N Iannuccelli; L Rask; H Ronne; K Lundström; N Reinsch; J Gellin; E Kalm; P L Roy; P Chardon; L Andersson
Journal:  Science       Date:  2000-05-19       Impact factor: 47.728

Review 6.  PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy.

Authors:  Michael H Gollob; Martin S Green; Anthony S L Tang; Robert Roberts
Journal:  Curr Opin Cardiol       Date:  2002-05       Impact factor: 2.161

7.  The binding of beta- and gamma-cyclodextrins to glycogen phosphorylase b: kinetic and crystallographic studies.

Authors:  Nikos Pinotsis; Demetres D Leonidas; Evangelia D Chrysina; Nikos G Oikonomakos; Irene M Mavridis
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

8.  AMPK beta subunit targets metabolic stress sensing to glycogen.

Authors:  Galina Polekhina; Abhilasha Gupta; Belinda J Michell; Bryce van Denderen; Sid Murthy; Susanne C Feil; Ian G Jennings; Duncan J Campbell; Lee A Witters; Michael W Parker; Bruce E Kemp; David Stapleton
Journal:  Curr Biol       Date:  2003-05-13       Impact factor: 10.834

9.  A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias.

Authors:  Emma R Hudson; David A Pan; John James; John M Lucocq; Simon A Hawley; Kevin A Green; Otto Baba; Tatsuo Terashima; D Grahame Hardie
Journal:  Curr Biol       Date:  2003-05-13       Impact factor: 10.834

10.  LKB1 is the upstream kinase in the AMP-activated protein kinase cascade.

Authors:  Angela Woods; Stephen R Johnstone; Kristina Dickerson; Fiona C Leiper; Lee G D Fryer; Dietbert Neumann; Uwe Schlattner; Theo Wallimann; Marian Carlson; David Carling
Journal:  Curr Biol       Date:  2003-11-11       Impact factor: 10.834

View more
  6 in total

1.  AKINbetagamma contributes to SnRK1 heterotrimeric complexes and interacts with two proteins implicated in plant pathogen resistance through its KIS/GBD sequence.

Authors:  Lionel Gissot; Cécile Polge; Mathieu Jossier; Thomas Girin; Jean-Pierre Bouly; Martin Kreis; Martine Thomas
Journal:  Plant Physiol       Date:  2006-10-06       Impact factor: 8.340

Review 2.  AMPK in cardiovascular health and disease.

Authors:  Najeeb A Shirwany; Ming-Hui Zou
Journal:  Acta Pharmacol Sin       Date:  2010-08-16       Impact factor: 6.150

Review 3.  AMPK: a cellular metabolic and redox sensor. A minireview.

Authors:  Najeeb A Shirwany; Ming-Hui Zou
Journal:  Front Biosci (Landmark Ed)       Date:  2014-01-01

4.  Functional demonstrations of starch binding domains present in Ostreococcus tauri starch synthases isoforms.

Authors:  Julieta Barchiesi; Nicolás Hedin; Diego F Gomez-Casati; Miguel A Ballicora; María V Busi
Journal:  BMC Res Notes       Date:  2015-10-28

Review 5.  Association between PRKAA1 rs13361707 T>C polymorphism and gastric cancer risk: Evidence based on a meta-analysis.

Authors:  You Jiang; Wenbo Li; Jun Lu; Xin Zhao; Liang Li
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

6.  Starch Synthesis in Ostreococcus tauri: The Starch-Binding Domains of Starch Synthase III-B Are Essential for Catalytic Activity.

Authors:  Julieta Barchiesi; Maria Belen Velazquez; Nicolas Palopoli; Alberto A Iglesias; Diego F Gomez-Casati; Miguel Angel Ballicora; Maria Victoria Busi
Journal:  Front Plant Sci       Date:  2018-10-25       Impact factor: 5.753

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.